(PCRB) Putnam Trust - Putnam ESG - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US7467296072

Core Bonds, ESG, US, Aggregate, Tax Advantaged

Description: PCRB Putnam Trust - Putnam ESG

Putnam ESG Core Bond ETF (PCRB) is a U.S.-domiciled exchange‑traded fund that targets the intermediate‑term core bond market while integrating environmental, social, and governance criteria into its security selection process.

The fund maintains a moderate duration (approximately 5 years) and a weighted average credit quality in the A‑range, positioning it to capture income from investment‑grade corporate and sovereign issuers. Its expense ratio sits near 0.20 %, and assets under management exceed $1.5 billion, reflecting strong investor demand for ESG‑aligned fixed‑income exposure.

Key performance indicators include a distribution yield around 2.5 % and a turnover rate below 30 %, indicating a relatively stable portfolio composition. ESG integration is quantified through a proprietary scoring model that screens for carbon intensity, labor practices, and governance standards, resulting in a higher-than‑average ESG rating among comparable core bond funds.

Macro drivers that dominate PCRB’s risk‑return profile are Federal Reserve policy on interest rates, inflation trends, and fiscal stimulus measures that affect the supply of investment‑grade debt. Additionally, the growing regulatory focus on sustainable finance and corporate ESG disclosures amplifies demand for bonds that meet stringent ESG criteria, providing a tailwind for the fund’s inflows and pricing dynamics.

PCRB ETF Overview

Market Cap in USD 820m
Category Intermediate Core Bond
TER 0.35%
IPO / Inception 2023-01-19

PCRB ETF Ratings

Growth Rating 52.9%
Fundamental -
Dividend Rating 59.4%
Return 12m vs S&P 500 -11.9%
Analyst Rating -

PCRB Dividends

Dividend Yield 12m 3.99%
Yield on Cost 5y 4.31%
Annual Growth 5y 8.15%
Payout Consistency 100.0%
Payout Ratio %

PCRB Growth Ratios

Growth Correlation 3m 87.3%
Growth Correlation 12m 54.8%
Growth Correlation 5y 88.4%
CAGR 5y 3.63%
CAGR/Max DD 5y 0.50
Sharpe Ratio 12m 0.70
Alpha -0.86
Beta -0.034
Volatility 4.26%
Current Volume 29.5k
Average Volume 20d 11.3k
Stop Loss 47.5 (-3.1%)
Signal 1.48

What is the price of PCRB shares?

As of August 30, 2025, the stock is trading at USD 49.04 with a total of 29,500 shares traded.
Over the past week, the price has changed by +0.13%, over one month by +1.07%, over three months by +2.74% and over the past year by +3.09%.

Is Putnam Trust - Putnam ESG a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, Putnam Trust - Putnam ESG (NYSE ARCA:PCRB) is currently (August 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 52.93 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PCRB is around 47.73 USD . This means that PCRB is currently overvalued and has a potential downside of -2.67%.

Is PCRB a buy, sell or hold?

Putnam Trust - Putnam ESG has no consensus analysts rating.

What are the forecasts/targets for the PCRB price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 52 6%

Last update: 2025-08-23 04:46

PCRB Fundamental Data Overview

Market Cap USD = 820.3m (820.3m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 820.3m USD (820.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 820.3m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 820.3m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(820.3m)/V(0.0) * Re(5.89%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 5.89% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for PCRB ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle